A Study to Assess the Pharmacokinetic Profile of an Investigational Formulation of Buprenorphine HCl/Naloxone HCl 8mg/2mg Capsules Relative to the Pharmacokinetic Profile of Suboxone (Buprenorphine HCl/Naloxone HCl 8mg/2mg Sublingual Tablets).
Phase of Trial: Phase I
Latest Information Update: 02 Oct 2017
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Nanotherapeutics; Ology Bioservices
- 02 Oct 2017 According to a Ology Bioservices media release, Nanotherapeutics changed its name to Ology Bioservices.
- 28 Jun 2017 Last checked against ClinicalTrials.gov record.
- 10 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.